Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on April 29, 2026

Apr. 29, 2026

Integral BioSystems to Present NanoM-Wafer™ Artificial Tear Film Ocular Insert at ARVO 2026 in Denver

Indeterminate EIN Presswire

Apr. 29, 2026

Integral BioSystems to Present on the NanoM-Wafer Technology at ARVO 2026

Indeterminate EIN Presswire

Apr. 29, 2026

Integral BioSystems to Present on OcuHeal-UV400+, an UV-Protective LNP Eyedrop

Indeterminate EIN Presswire

Apr. 29, 2026

Joined Bio Launches New Platform Capabilities that Put Participants in Control of Their Complete Health Picture

Indeterminate EIN Presswire

Apr. 29, 2026

LogicMark, Inc. to Announce First Quarter 2026 Financial Results on May 13, 2026

Indeterminate GlobeNewswire

Apr. 29, 2026

EyeCool Therapeutics Announces New ETX-4143 Data to Be Presented at ARVO 2026

Indeterminate EIN Presswire

Apr. 29, 2026

OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer

Indeterminate GlobeNewswire

Apr. 29, 2026

Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026

Indeterminate GlobeNewswire

Apr. 29, 2026

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 29, 2026

Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Apr. 29, 2026

Serotonin Centers Opens Second North Texas Location in Fort Worth, Expanding Physician-Led Longevity Care

Indeterminate GlobeNewswire

Apr. 29, 2026

LifeStance to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Apr. 29, 2026

RxSight, Inc. to Present at the Bank of America Healthcare Conference

Indeterminate GlobeNewswire

Apr. 29, 2026

Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026

Indeterminate GlobeNewswire

Apr. 29, 2026

Revolution Medicines to Report Financial Results for First Quarter 2026 After Market Close on May 6, 2026

Indeterminate GlobeNewswire

Apr. 29, 2026

Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026

Indeterminate GlobeNewswire

Apr. 29, 2026

Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026

Indeterminate GlobeNewswire

Apr. 29, 2026

Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference

Indeterminate GlobeNewswire

Apr. 29, 2026

Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026

Indeterminate GlobeNewswire

Apr. 29, 2026

AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO

Indeterminate GlobeNewswire